NYSEARCA:TEUM - NYSE Arca - US69946T2078
NEW YORK, Aug. 26, 2021 /PRNewswire/ -- Pareteum Corporation (OTC: TEUM), a global cloud Communications-Platform-as-a-Service (CPaaS) company, tod...
- Net loss attributable to common equity improved 24% to $7.2 million in Q1 2021, down from $9.4 million in Q1 2020
- Cayon plans to reach more than 10 mobile brands and over 100,000 subscribers by the end of 2021
Before 10 a.m. ET Wednesday, 3 stocks hit new 52-week lows. Highlights: The largest company in terms of market cap to set a new 52-week low was Global Blood Therapeutics (...
NEW YORK, June 17, 2021 /PRNewswire/ -- Pareteum Corporation (OTC: TEUM), a global cloud Communications-Platform-as-a-Service (CPaaS) company, tod...
- 2020 total revenue of $69.6 million, 12% year-over-year growth
NEW YORK, June 16, 2021 /PRNewswire/ -- Pareteum Corporation (OTC: TEUM), a global cloud Communications-Platform-as-a-Service (CPaaS) company, wil...
NEW YORK, May 17, 2021 /PRNewswire/ -- Pareteum Corporation (OTC: TEUM), a global cloud Communications-Platform-as-a-Service (CPaaS) company, toda...
- Preliminary 2020 total revenue of $69.6 million, 12% year-over-year growth despite impact from the pandemic
Another milestone completed in returning to a normal cadence of public company reporting
A Significant Milestone and Progress in the Restatement
Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares surged 237.1% to close at $18.00 on Wednesday in reaction to a positive data readout. Bemarituzumab, a targeted...